Company Data

Avalo Therapeutics Inc.

Ticker
AVTX
Current Price
$3.59 -0.83%
Market Cap
$38.9M
Price Target
Refer to Report
Volume
33.4K
52wk Range
$3.39 - $16
Advanced Market Data

Overview

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy